Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines

J. Whang-Peng, E. C. Lee, C. S. Kao-Shan, K. Seibert, Marc E Lippman

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Cytogenetic studies of the human breast cancer cell line MCF-7 and the sublines derived from it demonstrated extensive aneuploidy with both numerical and structural abnormalities and a wide range of heteroploidy. Detailed G-banding analyses showed that loss of marker chromosomes was a rare event, while formation of additional structural abnormalities was very common in these long-term cultures. All chromosomes were involved in these abnormalities. Loss of a morphologically normal X-chromosome may be related to the loss of estrogen receptors in these cell lines. With the exception of one subline, all cell lines had a short homogeneously staining region (SHR) on chromosome 7. Although the parent MCF-7 line had tetrahydrofolate dehydrogenase levels within the normal range, a lengthened HSR has been found in MCF-7 lines that are resistant to methotrexate. This observation strongly favours the association of an increased level of tetrahydrofolate dehydrogenase with HSR. In conclusion, the inherent genetic instability in this group of related cell lines may explain the heterogeneity found in this tumor. Continuous chromosomal rearrangements and numerical changes may reflect an ongoing process of selection and adaptation in these cell lines established from a breast carcinoma and may be characteristic of the aggressiveness of this neoplasm.

Original languageEnglish
Pages (from-to)687-695
Number of pages9
JournalJournal of the National Cancer Institute
Volume71
Issue number4
StatePublished - Dec 1 1983
Externally publishedYes

Fingerprint

Cytogenetics
Breast Neoplasms
Cell Line
Tetrahydrofolate Dehydrogenase
Chromosomes, Human, Pair 7
X Chromosome
Aneuploidy
Genetic Markers
Methotrexate
Estrogen Receptors
Neoplasms
Reference Values
Chromosomes
Staining and Labeling

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Whang-Peng, J., Lee, E. C., Kao-Shan, C. S., Seibert, K., & Lippman, M. E. (1983). Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. Journal of the National Cancer Institute, 71(4), 687-695.

Cytogenetic studies of human breast cancer lines : MCF-7 and derived variant sublines. / Whang-Peng, J.; Lee, E. C.; Kao-Shan, C. S.; Seibert, K.; Lippman, Marc E.

In: Journal of the National Cancer Institute, Vol. 71, No. 4, 01.12.1983, p. 687-695.

Research output: Contribution to journalArticle

Whang-Peng, J, Lee, EC, Kao-Shan, CS, Seibert, K & Lippman, ME 1983, 'Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines', Journal of the National Cancer Institute, vol. 71, no. 4, pp. 687-695.
Whang-Peng J, Lee EC, Kao-Shan CS, Seibert K, Lippman ME. Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. Journal of the National Cancer Institute. 1983 Dec 1;71(4):687-695.
Whang-Peng, J. ; Lee, E. C. ; Kao-Shan, C. S. ; Seibert, K. ; Lippman, Marc E. / Cytogenetic studies of human breast cancer lines : MCF-7 and derived variant sublines. In: Journal of the National Cancer Institute. 1983 ; Vol. 71, No. 4. pp. 687-695.
@article{f49227fabc9d4065958c3a71249a7a7f,
title = "Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines",
abstract = "Cytogenetic studies of the human breast cancer cell line MCF-7 and the sublines derived from it demonstrated extensive aneuploidy with both numerical and structural abnormalities and a wide range of heteroploidy. Detailed G-banding analyses showed that loss of marker chromosomes was a rare event, while formation of additional structural abnormalities was very common in these long-term cultures. All chromosomes were involved in these abnormalities. Loss of a morphologically normal X-chromosome may be related to the loss of estrogen receptors in these cell lines. With the exception of one subline, all cell lines had a short homogeneously staining region (SHR) on chromosome 7. Although the parent MCF-7 line had tetrahydrofolate dehydrogenase levels within the normal range, a lengthened HSR has been found in MCF-7 lines that are resistant to methotrexate. This observation strongly favours the association of an increased level of tetrahydrofolate dehydrogenase with HSR. In conclusion, the inherent genetic instability in this group of related cell lines may explain the heterogeneity found in this tumor. Continuous chromosomal rearrangements and numerical changes may reflect an ongoing process of selection and adaptation in these cell lines established from a breast carcinoma and may be characteristic of the aggressiveness of this neoplasm.",
author = "J. Whang-Peng and Lee, {E. C.} and Kao-Shan, {C. S.} and K. Seibert and Lippman, {Marc E}",
year = "1983",
month = "12",
day = "1",
language = "English",
volume = "71",
pages = "687--695",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Cytogenetic studies of human breast cancer lines

T2 - MCF-7 and derived variant sublines

AU - Whang-Peng, J.

AU - Lee, E. C.

AU - Kao-Shan, C. S.

AU - Seibert, K.

AU - Lippman, Marc E

PY - 1983/12/1

Y1 - 1983/12/1

N2 - Cytogenetic studies of the human breast cancer cell line MCF-7 and the sublines derived from it demonstrated extensive aneuploidy with both numerical and structural abnormalities and a wide range of heteroploidy. Detailed G-banding analyses showed that loss of marker chromosomes was a rare event, while formation of additional structural abnormalities was very common in these long-term cultures. All chromosomes were involved in these abnormalities. Loss of a morphologically normal X-chromosome may be related to the loss of estrogen receptors in these cell lines. With the exception of one subline, all cell lines had a short homogeneously staining region (SHR) on chromosome 7. Although the parent MCF-7 line had tetrahydrofolate dehydrogenase levels within the normal range, a lengthened HSR has been found in MCF-7 lines that are resistant to methotrexate. This observation strongly favours the association of an increased level of tetrahydrofolate dehydrogenase with HSR. In conclusion, the inherent genetic instability in this group of related cell lines may explain the heterogeneity found in this tumor. Continuous chromosomal rearrangements and numerical changes may reflect an ongoing process of selection and adaptation in these cell lines established from a breast carcinoma and may be characteristic of the aggressiveness of this neoplasm.

AB - Cytogenetic studies of the human breast cancer cell line MCF-7 and the sublines derived from it demonstrated extensive aneuploidy with both numerical and structural abnormalities and a wide range of heteroploidy. Detailed G-banding analyses showed that loss of marker chromosomes was a rare event, while formation of additional structural abnormalities was very common in these long-term cultures. All chromosomes were involved in these abnormalities. Loss of a morphologically normal X-chromosome may be related to the loss of estrogen receptors in these cell lines. With the exception of one subline, all cell lines had a short homogeneously staining region (SHR) on chromosome 7. Although the parent MCF-7 line had tetrahydrofolate dehydrogenase levels within the normal range, a lengthened HSR has been found in MCF-7 lines that are resistant to methotrexate. This observation strongly favours the association of an increased level of tetrahydrofolate dehydrogenase with HSR. In conclusion, the inherent genetic instability in this group of related cell lines may explain the heterogeneity found in this tumor. Continuous chromosomal rearrangements and numerical changes may reflect an ongoing process of selection and adaptation in these cell lines established from a breast carcinoma and may be characteristic of the aggressiveness of this neoplasm.

UR - http://www.scopus.com/inward/record.url?scp=0021032471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021032471&partnerID=8YFLogxK

M3 - Article

C2 - 6578363

AN - SCOPUS:0021032471

VL - 71

SP - 687

EP - 695

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 4

ER -